scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.0042-9007.2003.00371.X |
P698 | PubMed publication ID | 14633256 |
P2093 | author name string | Kjeldsen-Kragh J | |
Fagerhol MK | |||
Randen I | |||
Hauge R | |||
P2860 | cites work | Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum | Q24567463 |
Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
Genotyping fetal DNA by non-invasive means: extraction from maternal plasma | Q31920253 | ||
Mechanism of anti-D-mediated immune suppression--a paradox awaiting resolution? | Q34207523 | ||
Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed | Q35043252 | ||
Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service | Q40626763 | ||
The proportion of fetal nucleated red blood cells in maternal blood: estimation by FACS analysis. | Q50939459 | ||
Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
RhD Hemolytic Disease of the Newborn | Q59406030 | ||
Hepatitis C infection from anti-D immunoglobulin | Q71925764 | ||
Fluctuation of maternal and fetal free extracellular circulatory DNA in maternal plasma | Q73204793 | ||
Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients | Q73347782 | ||
Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR | Q77332308 | ||
The scientific basis of antenatal prophylaxis | Q77720014 | ||
Fetal RHD genotyping in maternal serum during the first trimester of pregnancy | Q78311739 | ||
Intact fetal cells in maternal plasma: are they really there? | Q78805727 | ||
P433 | issue | 4 | |
P921 | main subject | genotyping | Q912147 |
P304 | page(s) | 300-306 | |
P577 | publication date | 2003-11-01 | |
P1433 | published in | Vox Sanguinis | Q15708866 |
P1476 | title | Prenatal genotyping of RHD and SRY using maternal blood. | |
P478 | volume | 85 |
Q38178293 | Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis |
Q45984957 | Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groups. |
Q50246909 | Fetal RHD Genotyping from Circulating Cell-Free Fetal DNA in Plasma of Rh Negative Pregnant Women in Iran |
Q33917070 | Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women |
Q46444885 | Fetal RHD genotyping by PCR using plasma from D negative pregnant women |
Q54393922 | Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation. |
Q35976544 | Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn |
Q36861150 | Fetal blood group genotyping. |
Q50792929 | Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. |
Q34399889 | Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis |
Q54646324 | Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma. |
Q87466211 | Noninvasive fetal RhD genotyping |
Q54433693 | Noninvasive fetal RhD genotyping from maternal blood. |
Q35034936 | Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD |
Q37322448 | Prenatal diagnosis: update on invasive versus noninvasive fetal diagnostic testing from maternal blood |
Q36423155 | The Glass Slide Extraction System Snap Card Improves Non-Invasive Prenatal Genotyping in Pregnancies with Antibodies |
Q35879299 | The biology and diagnostic applications of fetal DNA and RNA in maternal plasma |
Search more.